TY - JOUR
T1 - Respiratory illness, β-agonists, and risk of idiopathic dilated cardiomyopathy
T2 - The washington, dc, dilated cardiomyopathy study
AU - Coughlim, Steven S.
AU - Metayer, Catherine
AU - Mccarthy, Ellen P.
AU - Mather, Frances J.
AU - Waldhom, Richard E.
AU - Gersh, Bernard J.
AU - Dupraw, Stephen
AU - Baughman, Kenneth L.
PY - 1995/8/15
Y1 - 1995/8/15
N2 - An epidemiologic study was earned out to examine the possible role of β-agonists and other respiratory medications in the development of idiopathic dilated cardiomyopathy. Associations with respiratory medications, bronchial asthma, emphysema, and chronic bronchitis were examined by comparing newly diagnosed cases (n= 129) ascertained from five Washington, DC, area hospitals for the period 1990-1992 with neighborhood controls (n= 258) identified by using a random digit dialing technique. The cases and controls were matched on sex and 5-year age intervals and were compared in the analysis using conditional logistic regression methods. A statistically significant association was observed between idiopathic dilated cardiomyopathy and history of emphysema or chronic bronchitis (adjusted odds ratio (OR) = 4.4, 95% confidence interval (Cl) 1.6-12.4). The association with bronchial asthma was of borderline significance (adjusted OR = 1.9, 95% Cl 0.9-4.2). Associations were also observed with use of oral β-agonists (adjusted OR= 3.4, 95% Cl 1.1-11.0) and β-agonist inhalers or nebulization (adjusted OR = 3.2, 95% Cl 1.4-7.1), as well as with use of oral corticosteroids, inhaled corticosteroids or cromolyn, and theophylline medications. A total of 20.0% (23 of 115) of the cases had a reported history of β-agonist inhaler use compared with 6.7% (17 of 254) of the controls. The strength of these associations was diminished when the temporal relation between exposure to β-agonist inhalers or oral preparations and clinical diagnosis of idiopathic dilated cardiomyopathy was taken into account, however, and the associations with duration of β-agonist medication use were not statistically significant (p > 0.05). The results of this study suggest, but do not prove, that use of β-agonists has an etiologic role in idiopathic dilated cardiomyopathy.
AB - An epidemiologic study was earned out to examine the possible role of β-agonists and other respiratory medications in the development of idiopathic dilated cardiomyopathy. Associations with respiratory medications, bronchial asthma, emphysema, and chronic bronchitis were examined by comparing newly diagnosed cases (n= 129) ascertained from five Washington, DC, area hospitals for the period 1990-1992 with neighborhood controls (n= 258) identified by using a random digit dialing technique. The cases and controls were matched on sex and 5-year age intervals and were compared in the analysis using conditional logistic regression methods. A statistically significant association was observed between idiopathic dilated cardiomyopathy and history of emphysema or chronic bronchitis (adjusted odds ratio (OR) = 4.4, 95% confidence interval (Cl) 1.6-12.4). The association with bronchial asthma was of borderline significance (adjusted OR = 1.9, 95% Cl 0.9-4.2). Associations were also observed with use of oral β-agonists (adjusted OR= 3.4, 95% Cl 1.1-11.0) and β-agonist inhalers or nebulization (adjusted OR = 3.2, 95% Cl 1.4-7.1), as well as with use of oral corticosteroids, inhaled corticosteroids or cromolyn, and theophylline medications. A total of 20.0% (23 of 115) of the cases had a reported history of β-agonist inhaler use compared with 6.7% (17 of 254) of the controls. The strength of these associations was diminished when the temporal relation between exposure to β-agonist inhalers or oral preparations and clinical diagnosis of idiopathic dilated cardiomyopathy was taken into account, however, and the associations with duration of β-agonist medication use were not statistically significant (p > 0.05). The results of this study suggest, but do not prove, that use of β-agonists has an etiologic role in idiopathic dilated cardiomyopathy.
KW - Asthma
KW - Bronchitis
KW - Cardiomyopathy
KW - Congestive
KW - Emphysema
UR - http://www.scopus.com/inward/record.url?scp=0029153498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029153498&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.aje.a117647
DO - 10.1093/oxfordjournals.aje.a117647
M3 - Article
C2 - 7625404
AN - SCOPUS:0029153498
SN - 0002-9262
VL - 142
SP - 395
EP - 403
JO - American journal of epidemiology
JF - American journal of epidemiology
IS - 4
ER -